The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members possess broad mitogenic and cell survival activities, and are involved in a variety of biological processes, including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth and invasion. This protein was isolated as a secreted factor that exhibits a growth-stimulating effect on cultured glial cells. In nervous system, this protein is produced mainly by neurons and may be important for glial cell development. Expression of the mouse homolog of this gene was found to be dependent on Sonic hedgehog (Shh) signaling. Mice lacking the homolog gene displayed a male-to-female sex reversal phenotype, which suggested a role in testicular embryogenesis.
FGF9 has also been shown to play a vital role in male development. Once activated by SOX9, it is responsible for forming a feedforward loop with Sox9, increasing the levels of both genes. The absence of Fgf9 causes an individual, even an individual with X and Y chromosomes, to develop into a female, as it’s needed to carry out important masculinizing developmental functions such as the multiplication of Sertoli cells and creation of the testis cords.
Naruo K, Seko C, Kuroshima K, et al. (1993). "Novel secretory heparin-binding factors from human glioma cells (glia-activating factors) involved in glial cell growth. Purification and biological properties.". J. Biol. Chem.268 (4): 2857–64. PMID8428960.
Mattei MG, Penault-Llorca F, Coulier F, Birnbaum D (1996). "The human FGF9 gene maps to chromosomal region 13q11-q12.". Genomics29 (3): 811–2. doi:10.1006/geno.1995.9926. PMID8575785.
Santos-Ocampo S, Colvin JS, Chellaiah A, Ornitz DM (1996). "Expression and biological activity of mouse fibroblast growth factor-9.". J. Biol. Chem.271 (3): 1726–31. doi:10.1074/jbc.271.3.1726. PMID8576175.
Chellaiah A, Yuan W, Chellaiah M, Ornitz DM (2000). "Mapping ligand binding domains in chimeric fibroblast growth factor receptor molecules. Multiple regions determine ligand binding specificity.". J. Biol. Chem.274 (49): 34785–94. doi:10.1074/jbc.274.49.34785. PMID10574949.
Plotnikov AN, Eliseenkova AV, Ibrahimi OA, et al. (2001). "Crystal structure of fibroblast growth factor 9 reveals regions implicated in dimerization and autoinhibition.". J. Biol. Chem.276 (6): 4322–9. doi:10.1074/jbc.M006502200. PMID11060292.
Hecht HJ, Adar R, Hofmann B, et al. (2001). "Structure of fibroblast growth factor 9 shows a symmetric dimer with unique receptor- and heparin-binding interfaces.". Acta Crystallogr. D Biol. Crystallogr.57 (Pt 3): 378–84. doi:10.1107/S0907444900020813. PMID11223514.
Tsai SJ, Wu MH, Chen HM, et al. (2002). "Fibroblast growth factor-9 is an endometrial stromal growth factor.". Endocrinology143 (7): 2715–21. doi:10.1210/en.143.7.2715. PMID12072406.
Alizadeh M, Miyamura N, Handa JT, Hjelmeland LM (2003). "Human RPE cells express the FGFR2IIIc and FGFR3IIIc splice variants and FGF9 as a potential high affinity ligand.". Exp. Eye Res.76 (2): 249–56. doi:10.1016/S0014-4835(02)00252-X. PMID12565813.
Wing LY, Chuang PC, Wu MH, et al. (2003). "Expression and mitogenic effect of fibroblast growth factor-9 in human endometriotic implant is regulated by aberrant production of estrogen.". J. Clin. Endocrinol. Metab.88 (11): 5547–54. doi:10.1210/jc.2003-030597. PMID14602803.
Fakhry A, Ratisoontorn C, Vedhachalam C, et al. (2005). "Effects of FGF-2/-9 in calvarial bone cell cultures: differentiation stage-dependent mitogenic effect, inverse regulation of BMP-2 and noggin, and enhancement of osteogenic potential.". Bone36 (2): 254–66. doi:10.1016/j.bone.2004.10.003. PMID15780951.